ANRO

NYSEStock

Alto Neuroscience, Inc.

$22.50+0.27 (+1.21%)

52-Week Range

$1.80

$23.05

Key Stats

Market Cap

699.0M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.59

Volume

183.6K

Avg Volume

203.2K

Performance

+33.03%

+30.53%

+489.66%

YTD

+34.00%

+603.48%

+7.39%

Price Chart

ETF Exposure

ANRO is held by 11 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
PSIL	AdvisorShares Psychedelics ETF	5.36%	56,823	$1.1M	$20.4M	1.84%
SBIO	ALPS Medical Breakthroughs ETF	0.42%	27,688	$578K	$139.0M	0.50%
RFLR	Innovator U.S. Small Cap Managed Floor ETF	0.11%	3,045	$64K	$59.7M	0.89%
IWC	iShares Micro-Cap ETF	0.10%	57,887	$1.2M	$1.27B	0.60%
IBB	iShares Biotechnology ETF	0.05%	199,402	$4.2M	$8.50B	0.44%
AVSC	Avantis U.S. Small Cap Equity ETF	0.01%	10,216	$213K	$2.37B	0.25%
AVTM	Avantis Total Equity Markets ETF 1	0.01%	3,437	$72K	$694.1M	0.23%
VXF	Vanguard Extended Market ETF	0.01%	291,906	$4.5M	$84.10B	0.05%
DCOR	Dimensional - US Core Equity 1 ETF	0.00%	1,813	$38K	$2.68B	0.14%
VTI	Vanguard Total Stock Market ETF	0.00%	875,781	$13.6M	$2.10T	0.03%
DFAS	Dimensional - US Small Cap ETF	0.00%	823	$17K	$12.82B	0.26%

About ANRO ETF Exposure

Alto Neuroscience, Inc. (ANRO) is held by 11 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 699.0M, ANRO is a widely held institutional stock. The stock currently trades at $22.50. Investors can gain exposure to ANRO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ANRO, sorted by portfolio weight.